Cliff Asness's EMN Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 440,762 shares of Eastman Chemical Company (EMN) worth $28.13 M, representing 0.01% of the portfolio. First purchased in 2012-Q4, this long-term strategic position has been held for 53 quarters.
Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in EMN, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2018, adding 853,390 shares. Largest reduction occurred in Q4 2018, reducing 796,919 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Eastman Chemical Company (EMN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Eastman Chemical Company (EMN) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +202,367 | Add 84.89% | 440,762 | $63.83 |
| Q3 2025 | +94,632 | Add 65.83% | 238,395 | $63.05 |
| Q2 2025 | -20,175 | Reduce 12.31% | 143,763 | $74.66 |
| Q1 2025 | -61,231 | Reduce 27.19% | 163,938 | $86.86 |
| Q4 2024 | -103,224 | Reduce 31.43% | 225,169 | $91.32 |
| Q3 2024 | -143,993 | Reduce 30.48% | 328,393 | $111.69 |
| Q2 2024 | +14,418 | Add 3.15% | 472,386 | $97.97 |
| Q1 2024 | -8,121 | Reduce 1.74% | 457,968 | $99.50 |
| Q4 2023 | +9,972 | Add 2.19% | 466,089 | $89.82 |
| Q3 2023 | -22,992 | Reduce 4.80% | 456,117 | $76.72 |
| Q2 2023 | -254,874 | Reduce 34.72% | 479,109 | $83.08 |
| Q1 2023 | -15,223 | Reduce 2.03% | 733,983 | $83.11 |
| Q4 2022 | +434,508 | Add 138.07% | 749,206 | $81.26 |
| Q3 2022 | +80,390 | Add 34.31% | 314,698 | $71.05 |
| Q2 2022 | +137,361 | Add 141.69% | 234,308 | $88.48 |
| Q1 2022 | -87,662 | Reduce 47.49% | 96,947 | $112.06 |
| Q4 2021 | -117,582 | Reduce 38.91% | 184,609 | $119.91 |
| Q3 2021 | -38,101 | Reduce 11.20% | 302,191 | $100.74 |
| Q2 2021 | -11,418 | Reduce 3.25% | 340,292 | $116.27 |
| Q1 2021 | -9,719 | Reduce 2.69% | 351,710 | $110.12 |
| Q4 2020 | -162,509 | Reduce 31.02% | 361,429 | $99.65 |
| Q3 2020 | -186,413 | Reduce 26.24% | 523,938 | $78.12 |
| Q2 2020 | -217,725 | Reduce 23.46% | 710,351 | $69.64 |
| Q1 2020 | -198,916 | Reduce 17.65% | 928,076 | $46.58 |
| Q4 2019 | +1,528 | Add 0.14% | 1.13 M | $79.26 |
| Q3 2019 | +623,630 | Add 124.27% | 1.13 M | $73.83 |
| Q2 2019 | -156,439 | Reduce 23.77% | 501,834 | $77.83 |
| Q1 2019 | +221,897 | Add 50.85% | 658,273 | $75.88 |
| Q4 2018 | -796,919 | Reduce 64.62% | 436,376 | $73.11 |
| Q3 2018 | -323,410 | Reduce 20.78% | 1.23 M | $95.72 |
| Q2 2018 | +853,390 | Add 121.34% | 1.56 M | $99.96 |
| Q1 2018 | -267,603 | Reduce 27.56% | 703,315 | $105.58 |
| Q4 2017 | -657,469 | Reduce 40.38% | 970,918 | $92.64 |
| Q3 2017 | -144,398 | Reduce 8.15% | 1.63 M | $90.49 |
| Q2 2017 | -542,823 | Reduce 23.44% | 1.77 M | $83.99 |
| Q1 2017 | +365,467 | Add 18.74% | 2.32 M | $80.80 |
| Q4 2016 | +845,159 | Add 76.49% | 1.95 M | $75.21 |
| Q3 2016 | +721,177 | Add 187.90% | 1.1 M | $67.68 |
| Q2 2016 | +127,867 | Add 49.96% | 383,805 | $67.90 |
| Q1 2016 | +175,595 | Add 218.56% | 255,938 | $72.23 |
| Q4 2015 | +41,591 | Add 107.33% | 80,343 | $67.51 |
| Q3 2015 | +19,184 | Add 98.04% | 38,752 | $64.72 |
| Q2 2015 | +3,847 | Add 24.47% | 19,568 | $81.82 |
| Q1 2015 | -72,460 | Reduce 82.17% | 15,721 | $69.27 |
| Q4 2014 | +25,545 | Add 40.78% | 88,181 | $75.86 |
| Q3 2014 | -22,800 | Reduce 26.69% | 62,636 | $80.90 |
| Q2 2014 | +29,900 | Add 53.84% | 85,436 | $87.35 |
| Q1 2014 | -57,388 | Reduce 50.82% | 55,536 | $86.21 |
| Q4 2013 | +68,120 | Add 152.04% | 112,924 | $80.70 |
| Q3 2013 | +13,646 | Add 43.80% | 44,804 | $77.89 |
| Q2 2013 | +31,158 | Add 0.00% | 31,158 | $70.00 |
| Q4 2012 | +87,870 | Add 0.00% | 87,870 | $68.06 |
Cliff Asness's Eastman Chemical Company Investment FAQs
Cliff Asness first purchased Eastman Chemical Company (EMN) in Q4 2012, acquiring 87,870 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Eastman Chemical Company (EMN) for 53 quarters since Q4 2012.
Cliff Asness's largest addition to Eastman Chemical Company (EMN) was in Q2 2018, adding 1,556,705 shares worth $155.61 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 440,762 shares of Eastman Chemical Company (EMN), valued at approximately $28.13 M.
As of the Q4 2025 filing, Eastman Chemical Company (EMN) represents approximately 0.01% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Eastman Chemical Company (EMN) was 2,315,608 shares, as reported at the end of Q1 2017.